Brazil Pharmaceutical Industry Market: Intellectual Property, Patents, and the Patent Cliff
The Brazil pharmaceutical industry market is navigating a complex intellectual‑property landscape, where patent‑protection timelines, compulsory‑licensing debates, and the “patent cliff” strongly influence competition and access. As originator‑drug patents expire, generics and biosimilars enter the market, reshaping pricing and market share. The Brazil Pharmaceutical Industry...
0 Comments 0 Shares 24 Views 0 Reviews
Sponsored